SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001840706-24-000059
Filing Date
2024-05-07
Accepted
2024-05-07 07:01:57
Documents
7
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 6-K q12024sophiageneticssa6-k.htm 6-K 16820
2 EX-99.1 sophiageneticssaex991q12024.htm EX-99.1 366825
3 EX-99.2 sophiageneticssaex992q12024.htm EX-99.2 183632
4 EX-99.3 sophiageneticssaex993q12024.htm EX-99.3 253306
5 EX-99.4 perceptivecreditagreement.htm EX-99.4 882202
6 EX-99.5 warrantcertificate.htm EX-99.5 211990
7 image_0.jpg GRAPHIC 96
  Complete submission text file 0001840706-24-000059.txt   1916048
Mailing Address LA PIECE, CH-1180 ROLLE V8 00000
Business Address LA PIECE, CH-1180 ROLLE V8 00000 41 21 694 10 60
SOPHiA GENETICS SA (Filer) CIK: 0001840706 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40627 | Film No.: 24919541
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)